Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (LLY)
NYSE:LLY
Pirtobrutinib, Idelalisib
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Phase IV
Not Yet Recruiting
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Oct 16, 2025
―
Pembrolizumab, Vepugratinib, Ev
Neoplasm Metastasis, Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase III
Not Yet Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Oct 09, 2025
―
Carboplatin, Bevacizumab, Gemcitabine, Paclitaxel, Pegylated Liposomal Doxorubicin, Topotecan, Ly4170156, Mirv
Neoplasm Metastasis, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms
Phase III
Not Yet Recruiting
A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Oct 07, 2025
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eli Lilly & Co (LLY) have in its pipeline
LLY is currently developing the following drugs: Brenipatide, Pirtobrutinib, Idelalisib, Ly3537031. These drug candidates are in various stages of clinical development as the company works toward FDA approval.